Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.
The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.
Inclusion Criteria:
Patient is newly diagnosed with Peripheral T-cell Lymphoma (PTCL):
Patient gives written informed consent
Exclusion Criteria:
Patient has other T- or NK-cell malignancies including:
Washington D.C., District of Columbia 20010, United States
Indianapolis, Indiana 46237, United States
Hackensack, New Jersey 07601, United States